Targeted vaccination in healthy school children - Can primary school vaccination alone control influenza?

Vaccine. 2015 Oct 5;33(41):5415-5424. doi: 10.1016/j.vaccine.2015.08.031. Epub 2015 Aug 24.

Abstract

Background: The UK commenced an extension to the seasonal influenza vaccination policy in autumn 2014 that will eventually see all healthy children between the ages of 2-16 years offered annual influenza vaccination. Models suggest that the new policy will be both highly effective at reducing the burden of influenza as well as cost-effective. We explore whether targeting vaccination at either primary or secondary schools would be more effective and/or cost-effective than the current strategy.

Methods: An age-structured deterministic transmission dynamic SEIR-type mathematical model was used to simulate a national influenza outbreak in England. Costs including GP consultations, hospitalisations due to influenza and vaccinations were compared to potential gains in quality-adjusted life years achieved through vaccinating healthy children. Costs and benefits of the new JCVI vaccination policy were estimated over a single season, and compared to the hypothesised new policies of targeted and heterogeneous vaccination.

Findings and conclusion: All potential vaccination policies were highly cost-effective. Influenza transmission can be eliminated for a particular season by vaccinating both primary and secondary school children, but not by vaccinating only one group. The most cost-effective policy overall is heterogeneous vaccination coverage with 48% uptake in primary schools and 34% in secondary schools. The Joint Committee on Vaccination and Immunisation can consider a modification to their policy of offering seasonal influenza vaccinations to all healthy children of ages 2-16 years.

Keywords: Cost-effectiveness analysis; Influenza; Mathematical model; QALYs; Schools; Vaccination.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Child
  • Child, Preschool
  • Cost of Illness
  • Cost-Benefit Analysis
  • Humans
  • Immunization Programs* / economics
  • Immunization Programs* / statistics & numerical data
  • Infant
  • Infant, Newborn
  • Influenza, Human / prevention & control*
  • Middle Aged
  • Models, Theoretical
  • Population Surveillance
  • Schools
  • United Kingdom / epidemiology
  • Vaccination* / economics
  • Vaccination* / statistics & numerical data
  • Young Adult